Research & Education
Welcome to the Cabrini Institute
New research hope for patients with recurrent prostate cancer
Ground-breaking research looking at the best way to locate recurrent prostate cancer in patients will change the future for thousands...
Breakthrough for BRCA-mutated early stage breast cancer
Breast cancer remains one of the most common cancers globally.
COVID-19 has resulted in disruptions to healthcare globally, including areas of cancer and palliative care
The COVID-19 pandemic has impacted us all in ways we could never have imagined.
New study aims to find an alternative therapy to tackle crippling bone pain suffered by cancer patients
A generous clinical research grant donation from the Sambor family will allow Dr Merlina Sulistio and Associate Professor Natasha Michael...
Celebrating International Clinical Trials Day
Every year on 20 May we celebrate International Clinical Trials Day, a day where we pay thanks to the clinical...
‘Revival’ cancer stem cells influence how bowel cancer patients respond to chemotherapy
A Cabrini researcher has found that ‘revival’ cancer stem cells influence how patients with bowel cancer respond to chemotherapy, which...
International study conducted at Cabrini highlights the complications of intubating critically ill patients
A study published last month in JAMA shows more than 40 per cent of critically ill patients suffer a life...
Cabrini researcher leads an international effort to understand a rare form of ovarian cancer
Cabrini researcher Associate Professor Yoland Antill, together with Professor Clare Scott from the Walter and Eliza Hall Institute, and Professor...
Exercise offers relief for osteoarthritis patients
A 66 year-old grandfather has managed to avoid major knee surgery for the past two years thanks to the Good...
A/Prof Jeremy Shapiro named inaugural winner of the Doug Lording Research Award
Named in honour of the founder of the Cabrini Institute, Associate Professor Doug Lording AM, the award is presented to...